TBO.com - TBO is Tampa Bay Online

For $1,000, Company Will Let You See Your Genome

ADVERTISEMENT

By NICHOLAS WADE, The New York Times

Published: November 17, 2007

The revolution in human genomics, though barely understood by professionals, is about to hit the street, at least for those able to pay about $1,000 for a glance at their entire genome.

The Icelandic company Decode Genetics announced Friday that it is launching a service that will assess a person's genome for disease risk, bodily traits like hair and eye color, and ancestral origins. Subscribers have to send in a scraping of cells from inside the cheek and a check for $985.

A similar service, using a smaller but custom-made analytic device, is expected to be announced soon by 23andMe, a Google-financed company founded by Linda Avey, a biotechnology executive, and Anne Wojcicki, a health-care investor married to Sergey Brin, Google's co-founder. The 23 in the company's name refers to the 23 pairs of chromosomes in the human genome. A third company, Navigenics, of Redwood Shores, Calif., is expected to focus on disease genes.

Entire Genome Examined

Unlike the present genetic testing and genetic genealogy companies, which look at a few specific genes, the three new services will sample the whole human genome.

Many people may welcome the rich new trove of data about their hereditary make-up and ancestry, but genetic counselors are concerned that some people may find the information hard to handle, given that much of the current genetic knowledge is related to a person's risk of developing common and often untreatable diseases.

The services will use devices known as SNP chips, which offer a cheap substitute for decoding the 3 billion units of the human genome, a task that would probably cost $1 million or so a person at present.

The chips, made by companies such as Illumina of San Diego and Affymetrix of Santa Clara, Calif., are programmed to determine the DNA unit at sites along the genome that are known to vary from person to person.

Chips Reveal DNA Coding

The chips thus capture the major points of difference - the single nucleotide polymorphism or "snip" - in an individual's DNA while ignoring the many sites at which all people have the same DNA unit.

Decode's service will use a chip that tests a person's DNA at one million sites along the genome.

The company will then compare this set of data, known as a genotype, with the patients' genotypes in its own and other databases that have been used in discovering disease-related SNPs. From this comparison the company will estimate a customer's relative risk of developing the 20 or so common diseases for which disease-related SNPs have been identified.

Decode will also test for genetic variants, discovered by its own and other scientists, that influence the color of a person's skin, hair and eyes, and whether or not they are prone to freckles.

Besides information about disease risk and normal physiology, Decode will also examine the Y chromosome and mitochondrial DNA, the only two elements of the genome that are always passed down essentially unchanged from one generation to the next. SNPs on the Y chromosome reflect the origin of a man's ancestors back to 50,000 years ago when modern humans first left their ancestral homeland in northeast Africa. Those on the mitochondrial DNA reflect the wanderings of women throughout the globe.

The significance of most variation in the human genome is presently unknown. Most of the SNPs studied so far have been identified in the course of searching for the genetic roots of common diseases, such as cancer, diabetes and heart disease. Because the diseases are common, many people possess the underlying SNPs. So any interpretation of a person's genome is at present heavily skewed toward generating ominous news.

This may alarm some customers, even though they will never get most or any of the diseases for which they simply have some genetic risk. There are undoubtedly genes that promote longevity and good health but far fewer of these have yet been spotted. And environmental factors, too, can affect whether certain genes are ever activated.
Genetic counselors long have been concerned that the growing availability of genomic information will outpace the ability to interpret it. Genetic information affects not only the person from whom it is obtained but also their family members. And it cannot ever be changed.

"If people can go into this testing knowing what its limits are, and can take it with a grain of salt, that's fine," said Angela Trepanier, incoming president of the National Society of Genetic Counselors. "But you have to be really careful about what you know and don't know."

Elizabeth Balkite, a genetic counselor in Durham, N.C., said that "I don't believe in keeping information from people but I'd be curious as to how useful this would be to the average individual." If the information is misunderstood, the field will be set back, she said.

Kari Stefansson, chief executive of Decode Genetics, said the genotyping information his company would provide was not the same as a genetic test. If customers felt they were at particular risk of a disease, they should get a proper test from their physician, he said.

"In our genomes is written the history of our family, the history of our nation and the history of our species," he said. "People can look at their own genomes and find where you and your family fit into human population history, so I think this is terribly exciting."

Share this:

Loading Comments...

Email Print

ADVERTISEMENT